» Articles » PMID: 38622315

Management of Surgical Diseases of Primary Hyperparathyroidism: Indications of the United Italian Society of Endocrine Surgery (SIUEC)

Abstract

A task force of the United Italian society of Endocrine Surgery (SIUEC) was commissioned to review the position statement on diagnostic, therapeutic and health‑care management protocol in parathyroid surgery published in 2014, at the light of new technologies, recent oncological concepts, and tailored approaches. The objective of this publication was to support surgeons with modern rational protocols of treatment that can be shared by health-care professionals, taking into account important clinical, healthcare and therapeutic aspects, as well as potential sequelae and complications. The task force consists of 12 members of the SIUEC highly trained and experienced in thyroid and parathyroid surgery. The main topics concern diagnostic test and localization studies, mode of admission and waiting time, therapeutic pathway (patient preparation for surgery, surgical treatment, postoperative management, management of major complications), hospital discharge and patient information, outpatient care and follow-up, outpatient initial management of patients with pHPT.

References
1.
Del Rio P, Polistena A, Chiofalo M, De Pasquale L, Dionigi G, Docimo G . Management of surgical diseases of thyroid gland indications of the United Italian Society of Endocrine Surgery (SIUEC). Updates Surg. 2023; 75(6):1393-1417. PMC: 10435599. DOI: 10.1007/s13304-023-01522-7. View

2.
Rosato L, Raffaelli M, Bellantone R, Pontecorvi A, Avenia N, Boniardi M . Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB). J Endocrinol Invest. 2014; 37(2):149-65. DOI: 10.1007/s40618-013-0022-0. View

3.
Eastell R, Arnold A, Brandi M, Brown E, DAmour P, Hanley D . Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009; 94(2):340-50. DOI: 10.1210/jc.2008-1758. View

4.
Zini M, Attanasio R, Cesareo R, Emmolo I, Frasoldati A, Gianotti L . AME position statement: primary hyperparathyroidism in clinical practice. J Endocrinol Invest. 2012; 35(7 Suppl):2-21. View

5.
Marx S . Hyperparathyroid genes: sequences reveal answers and questions. Endocr Pract. 2011; 17 Suppl 3:18-27. PMC: 3484688. DOI: 10.4158/EP11067.RA. View